Skip to main content
Journal of Virology logoLink to Journal of Virology
. 2021 Mar 10;95(7):e02180-20. doi: 10.1128/JVI.02180-20

Consequences of Phosphorylation in a Mononegavirales Polymerase-Cofactor System

Joseph R Gould a, Shihong Qiu a, Qiao Shang a, Terje Dokland a, Tomoaki Ogino b, Chad M Petit c, Todd J Green a,
Editor: Rebecca Ellis Dutchd
PMCID: PMC8092687  PMID: 33441337

Polymerase-cofactor interactions such as those addressed in this study are absolute requirements for mononegavirus RNA synthesis. Although cofactor phosphorylation is present in most of these interactions, its effect, if any, on this protein-protein interaction had not been addressed.

KEYWORDS: RNA-dependent RNA polymerase, nonsegmented negative-strand RNA viruses, nuclear magnetic resonance, replication, transcription, vesicular stomatitis virus

ABSTRACT

Vesicular stomatitis virus (VSV) is a member of the order Mononegavirales, which consists of viruses with genomes of nonsegmented negative-sense (NNS) RNA. Many insights into the molecular biology of NNS viruses were first made in VSV, which is often studied as a prototype for members of this order. Like those of other NNS viruses, the VSV RNA polymerase consists of a complex of the large protein (L) and the phosphoprotein (P). Recent discoveries have produced a model in which the N-terminal disordered segment of P (PNTD) coordinates the C-terminal accessory domains to produce a “compacted” L conformation. Despite this advance, the role of the three phosphorylation sites in PNTD has remained unknown. Using nuclear magnetic resonance spectroscopy to analyze the interactions between PNTD and the L protein C-terminal domain (LCTD), we demonstrated our ability to test sensitively for changes in the interface between the two proteins. This method showed that the binding site for PNTD on LCTD is longer than was previously appreciated. We demonstrated that phosphorylation of PNTD modulates its interaction with LCTD, and we used a minigenome reporter system to validate the functional significance of the PNTD-LCTD interaction. Using an electron microscopy approach, we showed that L bound to phosphorylated PNTD displays increased conformational heterogeneity in solution. Taken as a whole, our studies suggest a model in which phosphorylation of PNTD modulates its cofactor and conformational regulatory activities with L.

IMPORTANCE Polymerase-cofactor interactions such as those addressed in this study are absolute requirements for mononegavirus RNA synthesis. Although cofactor phosphorylation is present in most of these interactions, its effect, if any, on this protein-protein interaction had not been addressed. Our study is the first to address the effects of phosphorylation on P during its interactions with L in residue-by-residue detail. Since phosphorylation is the biologically relevant state of the cofactor, our demonstration of its effects on L conformation suggests that the structural picture of L during infection might be more complex than previously appreciated.

INTRODUCTION

Nonsegmented negative-sense (NNS) viruses represent numerous human pathogens, such as the Ebola and measles viruses. Vesicular stomatitis virus (VSV) is widely used as a prototype for the study of the molecular biology of NNS viruses. Studies in VSV were the first in the field to identify the unusual template of NNS viral RNA synthesis, which consists of genomic RNA, a nucleocapsid (N) protein (1, 2), and the unique polymerase, which includes both the conserved viral large (L) protein and the phosphoprotein (P) cofactor (1, 3, 4). Furthermore, VSV is relevant to human health, both as a potential oncolytic agent (5) and, more prominently, as a vaccine platform against the Ebola virus (6). Antigen presentation using VSV is being explored similarly as a strategy in vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (79).

The L proteins of Mononegavirales are highly conserved (10) and possess the enzymatic activities needed for mononegavirus RNA synthesis. In VSV, the L protein supplies RNA-dependent RNA polymerase (RDRP) (1, 3, 4), GDP polyribonucleotidyltransferase (PRNTase) capping (11), dispecific cap methyltransferase (MTase) (1214), and polyadenylate synthetase (15) activities. The L protein has a modular layout consisting of a ring-shaped core (∼150 kDa) that contains the RDRP and PRNTase activities from which extend three accessory domains: the connector domain (P binding), methyltransferase domain (cap methylation), and C-terminal domain (CTD or LCTD) (P binding) (1618). The structures of core regions from human metapneumovirus (HMPV) (19) and respiratory syncytial virus (RSV) (20), as well as full-length structures of L from rabies virus (RABV) (21) and parainfluenza virus 5 (PIV5) (22), show that the structures of L proteins are highly similar across the members of Mononegavirales.

In contrast to the L proteins, P proteins from each family within the Mononegavirales have both structured and unstructured components. From N terminus to C terminus, the VSV P protein is composed of the following regions: a structured nucleocapsid (N) protein chaperone (23, 24), a disordered region that binds L and supplies polymerase cofactor activity (P N-terminal disordered [PNTD] region) (18, 25, 26), a structured homodimerization interface (2729), a short, flexible linker (26), and a C-terminal structured domain that binds the assembled N-RNA complex (30, 31) (Fig. 1A). PNTD contains a subregion, referred to as the L stimulatory domain (PLSD). This stretch of residues 81 to 106 appears to mediate initiation competence (25, 32) and essentially corresponds to the region of PNTD bound to the RDRP and connector domains of L (17, 18). P proteins and functional equivalents thereof (such as VP35 in Ebola virus) are present throughout the order. Although domain organization and oligomerization state differ between viral genera, P proteins can be broadly described as flexible, charged, and multimeric cofactors of the L protein polymerases.

FIG 1.

FIG 1

Overview of VSV P and the polymerase-cofactor complex. (A) Structural layout of VSV P, labeled and color-coded by domain. A linear sequence cartoon is shown below. The phosphorylation targets in the P N-terminal disordered (PNTD) cofactor region (residues S60, T62, and S64) are circled. (B) Structure of the VSV L-PNTD complex, labeled and color-coded by domain, with PNTD shown in blue as in panel A. The white dashed line shows the putative approximate position of VSV P residues 57 to 81 near the L C-terminal domain (LCTD), which includes the phosphorylation targets. A linear sequence cartoon of L is shown below. The PDB accession codes for the structures visualized are as follows: 3PMK (P chaperone), 2FQM (P homodimerization), 3HHW (P template-binding), and 6U1X (L-PNTD complex).

P has been shown to be phosphorylated in cellula, and a subset of phosphorylation sites have been localized to PNTD (residues S60, T62, and S64) (33, 34). These modifications are mediated by casein kinase II (35). P protein derived from the virus particle is phosphorylated (36), although the sequence in which phosphorylation takes place on the PNTD sites relative to the phosphorylation targets in the N-terminal (37) and C-terminal (38) regions of the protein is unclear. Phosphorylation has a protranscriptional effect (33, 35, 39), but what exactly the modification does has not been definitively established. In the existing structural studies of the VSV L-PNTD complex (1618, 25), only nonphosphorylated P was used. Furthermore, the phosphorylation targets are missing in the L-PNTD cryoelectron microscopy (cryo-EM) structure (18). Adding to the complexity of this picture, it was found that P expressed in Sf21 insect cells stimulated initiation by L more effectively than did P expressed in Escherichia coli (32), an effect possibly explainable by phosphorylation. In an in vitro transcription system, Sf21 cell-expressed P with mutagenized phosphorylation sites was less active than the wild type (40), though, interestingly, more active than E. coli-expressed P in previous observations, potentially indicating that phosphorylation events both inside and outside the PNTD region could contribute to cofactor activity. Phosphorylation of P proteins and of functional analogs thereof has been observed in other members/families of the Mononegavirales (41, 42), although its role in polymerase-cofactor interactions has, similarly, not been characterized. Furthermore, mutants of VSV P with modified phosphorylation sites are known to decrease viral RNA synthesis (39, 43) and abrogate the ability of P to prevent cellular RNA from binding the N protein (40). Taking these observations as a whole, the lack of information on how the phosphorylation of the cofactor P affects its interactions with the polymerase is a notable gap in the knowledge of the field. A graphical depiction of the L-PNTD complex with emphasis on the potential position of the phosphorylated residues is provided in Fig. 1B.

In order to gain a more complete picture of the VSV L-PNTD complex, we sought to determine a role for phosphorylation in the L-PNTD interaction. Using a biophysical approach, we demonstrated that nuclear magnetic resonance (NMR) spectroscopy can be used to probe for phosphorylation-induced changes to L-P interactions with resolution at the amino acid level. We report that phosphorylation alters the LCTD-PNTD interaction and increases the conformational heterogeneity of the L-PNTD complex. We supplemented these studies with a minigenome reporter system, which allowed us to quantify the effects of mutations in the P protein on viral RNA synthesis and revealed the importance of a conserved motif in the LCTD-PNTD interaction. Taken as a whole, our data suggest that PNTD phosphorylation modulates the balance of L between its compact and noncompact conformational states, potentially representative of initiation and elongation, respectively.

RESULTS

The PNTD-LCTD interface includes the phosphorylated region of PNTD.

Recent biophysical and cryo-EM studies have shown that the PNTD-L interactions in VSV take place in the RDRP, connector, and C-terminal domains of the L protein (17, 18). However, the residues that are sites of phosphorylation in PNTD (S60, T62, S64) (Fig. 1) were not resolved in those structural studies. Because of its residue-level resolution and extreme sensitivity, we employed NMR to study the interaction between PNTD and LCTD.

To determine the effect of phosphorylation on the interaction of PNTD with LCTD, we used an NMR technique known as chemical shift perturbation (CSP) analysis. This technique was used previously by our lab to detail the interaction between the L and P proteins from VSV with resolution at the level of single amino acids (17). The first step in this analysis is to obtain chemical shift assignments for the protein of interest. To this end, PNTD was isotopically labeled with 15N and 13C to enable us to obtain the high-quality triple-resonance spectra required for these assignments. We successfully assigned peaks for 62 of 66 nonproline residues in the unphosphorylated and phosphorylated PNTD spectra, using the same methods as in our previous study (17). Once the backbone resonances were assigned, we obtained two heteronuclear spin quantum coherence (HSQC) spectra for the CSP analysis. The first HSQC spectrum that we recorded consisted of the 15N-labeled PNTD by itself, while the second HSQC spectrum was 15N-labeled PNTD in the presence of a nonisotopically labeled construct consisting of the VSV L methyltransferase and C-terminal domains, termed MT/CT. Two equivalent experiments were then performed with phosphorylated PNTD. To perform the CSP analysis, we quantified both changes to position and changes to the signal strength of amide chemical shifts upon the addition of the MT/CT construct. Using this method, we found significant changes to a stretch of amino acids in P (residues 49 to 68), specifically a signal depletion of 80% or more, upon MT/CT addition, of all residues in the stretch except for residues 64, 65, and 67 (residue 66 was a proline and therefore was not visible in this experiment) (Fig. 2). We noted that our assignment of residues 49 to 68 was longer than what had been observed in the L-PNTD complex structure of residues 49 to 56. In that structure, however, residues 57 to 68 (in addition to others) were not resolved (18). Our findings concur with those of the previous study (18) and encompass the residues observed in that structure but suggest a larger binding region, observed potentially due to the more sensitive nature of the NMR experiments. Because the C terminus of the known binding site would direct any extension away from the methyltransferase, we assert that the interaction detected likely is not affected by the methyltransferase portion of the MT/CT construct.

FIG 2.

FIG 2

NMR of the MT/CT-PNTD interaction. (A) HSQC spectra of PNTD (residues 35 to 106) either in an apo state (black) or with LMT/CT (residues 1596 to 2109) added (green). (B) The experimental setup used for panel A was repeated, but PNTD was phosphorylated. Apo spectra (red) and LMT/CT-added spectra (blue) are shown. In panels A and B, boxes highlight examples of residues that undergo signal depletion upon LMT/CT addition. (C) Signal intensities of LMT/CT-added spectra normalized to those of apo state spectra for unphosphorylated (black) and phosphorylated (green) PNTD. The red horizontal line indicates the signal loss cutoff for determining an interaction in the unphosphorylated spectra (80% or more).

The presence of phosphorylation in PNTD is known to be a positive regulator of viral RNA synthesis (33), although it has been demonstrated in an in vitro context that an overabundance of P protein expressed in Sf21 cells (which express casein kinase II) can be an RNA synthesis initiation suppressant (32). Having demonstrated that the region containing the phosphorylation targets S60, T62, and S64 interacts with LCTD, we used a sample of PNTD that had been triphosphorylated in vitro and examined using mass spectrometry (Fig. 3) to repeat the experiments described above (Fig. 2B and C). We noted that signal loss upon the addition of MT/CT was mitigated about 20 to 40% by phosphorylation in the region of interest. In P residues 49 to 68, only residue D61 showed a greater amount of signal loss in the phosphorylated-PNTD experiment than in the nonphosphorylated-PNTD experiment, and this difference was only about 1%. Taken as a whole, our NMR experiments show that residues 49 to 68 of P are involved with interactions with the LCTD and that phosphorylation of PNTD modulates this interaction. It should be noted that the parameters of the NMR experiments that were used to assess the effect of phosphorylation on the interaction between PNTD and MT/CT were equivalent. This equivalence in experimental design allows a robust and direct comparison of the spectra for the phosphorylated and nonphosphorylated forms of PNTD. Furthermore, the spectra of phosphorylated and unphosphorylated PNTD are essentially superimposable with the exception of the phosphorylated residues; in other words, changes to binding upon phosphorylation likely did not come from a major structural change to PNTD upon phosphorylation prior to L binding.

FIG 3.

FIG 3

Phosphorylation of PNTD. An intact phosphorylated sample of PNTD was analyzed using mass spectrometry. The red chevron indicates a peak cluster at a charge state of +5 and an m/z centroid of roughly 1,676 (corresponding to a mass of 8,375 Da, against a predicted molecular weight of 8,374 Da for the triphosphorylated species). The white chevron indicates a cluster with an m/z centroid of 1,660 (corresponding to a mass of 8,295 Da, against a predicted molecular weight of 8,294 Da for the diphosphorylated species). Black chevrons indicate where centroids for the monophosphorylated and unphosphorylated species would be expected (m/z 1,644 and 1,628, respectively). Higher-mass species, likely corresponding to adducts, are highlighted with a red bracket.

A conserved and functionally important region of PNTD is responsible for the LCTD–PNTD interaction.

In the VSV L-PNTD structure, residues 49 to 56 of P are resolved in contact with LCTD; however, the continued length of PNTD is presumably proximal to the CTD (18). This additional segment of P putatively bridges the gap between residues 56 and 82, terminal residues of resolved portions of PNTD. Our NMR analysis indicated that the PNTD-LCTD interaction may extend as far as residue 68, so we decided to examine the conservation and potential functional consequences of residues 49 to 68.

We compared the sequences of phosphoproteins from other members of the genus Vesiculovirus and from members of the closely related Sprivivirus genus. We identified a conserved PSYΩ (where Ω is an aromatic residue) motif corresponding to VSV residues 51 to 54 followed by the relatively acid-rich stretch flanking the phosphorylation sites of S60, T62, and S64 (Fig. 4).

FIG 4.

FIG 4

Conservation of PNTD among vesiculoviruses and spriviviruses. Phosphoprotein sequences from each of the viruses listed were aligned against that of VSV, and the portions aligned against VSV P residues 49 to 68 are shown here. A conserved motif and the three phosphorylation sites of VSV P are marked. Abbreviations: VSIV, vesicular stomatitis Indiana virus; VSNV, vesicular stomatitis New Jersey virus; VSAV, vesicular stomatitis Alagoas virus; CARV, Carajas virus; CHPV, Chandipura virus; COCV, Cocal virus; ISFV, Isfahan virus; MARAV, Maraba virus; PIRYV, Piry virus; JURV, Jurona virus; PERIV, Perinet virus; YUBOV, Yug Bogdanovac virus; PFRV, pike fry virus; SVCV, spring viremia of carp virus.

We next examined the functional consequences of alanine substitutions in the PSYΩ motif and other amino acids in the region implicated by our NMR studies. We used a minigenome reporter system, in which cells are transfected with plasmids encoding the VSV N, P, and L proteins, along with a plasmid encoding a VSV-based minireplicon containing a single reporter luciferase gene. This system had previously allowed us to examine the consequences of disrupting connector-PNTD interactions (17). We quantified reporter activity normalized to a transfection control and noted a number of functionally important substitutions. Substitutions P51A, S52A, and Y53A showed near-total functional loss. Interestingly, F54A also showed reporter activity suppression of ∼40%. Reporter activity loss for the three phosphorylation sites increased toward the C terminus; in other words, S64A had more suppression than T62A, which, in turn, had more than S60A. The loss of two acidic residues, D61A and E65A, resulted in activity losses of roughly 25% and 50%, respectively. Because casein kinase II targets residues with acidic content toward the carboxy terminus, these two substitutions might have had an effect on phosphorylation. Surprisingly, P66A, an alanine substitution at a nonconserved position, showed near-total reporter activity loss. Two modest increases to reporter activity, resulting from the substitutions D58A and D59A, were also observed. We also replaced the three phosphorylation sites with either alanines (P3A) or phosphomimetic glutamic acids (P3E). As expected (40, 43), P3A demonstrated a loss of activity, while P3E maintained roughly 20% of activity (Fig. 5A). Western blotting was used to validate proper expression of P mutants (Fig. 5B). Taking our findings as a whole, we can confirm that both conserved and VSV-unique residues in the N terminus of PNTD have functional consequences in terms of viral RNA synthesis.

FIG 5.

FIG 5

Minigenome reporter analysis of mutagenized VSV P. (A) A minigenome dual-luciferase reporter assay was carried out with the listed amino acid substitutions in P. Results for wild-type P, used as a positive control (+), and a negative control without P (–P) are provided as well. The horizontal axis break separates two batches of experiments. Error bars represent 95% confidence intervals for three replicates. (B) Each of the samples used in the minigenome reporter assay was examined for VSV P content by Western blotting, with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a control.

Phosphorylation of PNTD alters its conformational regulatory effect on L.

Given our NMR studies, which showed that phosphorylation alters the PNTD-LCTD interaction, and the current model of full-length PNTD as a one-copy steric restraint on the RDRP, connector, and CTD domains of L, we examined the effects of phosphorylated and unphosphorylated PNTD on L protein conformation. We approached this by using negative-stain electron microscopy. Imaging was carried out for apo L, L with unphosphorylated PNTD, and L with phosphorylated PNTD. From each data set, ∼3,000 to 7,000 particles were picked and used to generate 2-dimensional (2D) class averages (Fig. 6). The 2D class averages were categorized as “compact” or “noncompact,” where compact classes showed a condensed, bean-shaped morphology while noncompact classes displayed a ring-shaped core with either poorly resolved or punctiform density in proximity. In previous studies (16, 25), the ring-shaped core was found to correspond to the RDRP and PRNTase core of the L protein, and the puncta to the accessory domains.

FIG 6.

FIG 6

Negative-stain electron microscopy of the L-PNTD complex. (A) Twelve class averages each from samples of apo L, L with phosphorylated PNTD, and L with unphosphorylated PNTD. Each class average is bordered in red or blue, corresponding to its assignment to the compact or noncompact state, respectively. The number given for each class average corresponds to the fraction of particles in the final data set that it represents. (B) Examples of class averages from each sample are shown for the compact and noncompact states. (C) Table summarizing the percentages of particles in the compact and noncompact states in each sample.

We found that the unphosphorylated L-PNTD complex overwhelmingly preferred the compact state (no noncompact classes were present). In contrast, the apo L sample showed only low levels of the compact state (∼7%), with most classes showing punctiform accessory domains or a general lack of definition in the accessory domains. The phosphorylated sample showed a general increase in heterogeneity and was found to contain a mixture of compact and noncompact states (roughly 82% and 18%, respectively). These results indicated that the sample with the phosphorylated cofactor had a greater amount of conformational heterogeneity than the unphosphorylated equivalent, specifically in the accessory domains of the L protein.

DISCUSSION

Many of the fundamental insights into negative-strand virus molecular biology have been generated from studying VSV. As polymerase studies specifically approach increasing levels of structural detail, it is necessary to characterize the role of known posttranslational modifications of the polymerase components L and P in order to obtain a better mechanistic understanding. In this study, we have demonstrated that the phosphorylation of the P cofactor has an effect on L-P interactions.

The modular layout of the L protein has proven advantageous in isolating different components of the protein for study. In both this report and a previous report detailing connector-P interactions (17), we have demonstrated that solution NMR allows for the sensitive study of L-P interactions on a residue-by-residue basis, without requiring the purification of full-length L. This study, in particular, also shows that NMR studies can detect interacting residues that might not be visible to high- or intermediate-resolution cryo-EM due to mobility, partial occupancy, or other issues. Although this study used fragments of L and P rather than full-length proteins, the regions of each protein implicated by our NMR results were consistent with available structural information (18). In the cryo-EM reconstruction of the L-PNTD complex, the LCTD-binding region of PNTD positions the C-terminal residues of the cofactor away from the methyltransferase domain. Our study detects further interaction by PNTD with the C-terminal residues, so we assert that our inclusion of the methyltransferase in our construct did not result in alterations to the interaction. It should, however, be noted that the use of fragments can yield information on local protein-protein interactions but may undersample the interactions of the more-intact protein-protein system.

Our NMR studies implicated PNTD residues 49 to 68, which included a highly conserved PSYΩ motif, in interactions with LCTD. Mutagenesis in these residues was examined in a minigenome reporter system. Substitution of P51, S52, or Y53 greatly suppressed reporter activity, while the F54A mutation, though still significant, had a more modest effect. The other highly suppressive mutant described in this study is the P66A mutant. Because prolines lack an amide hydrogen, they are not visible to HSQC NMR, and as such it cannot be said if the signal suppression indicative of an interaction that we observed for VSV P49–68 could be observed for P66 specifically. The existing VSV L-PNTD structure could not place this residue, presumably due to structural disorder, but it likely lies between the resolved CTD and RDRP binding sites for PNTD. We hypothesize that residue P66 either enables an important structural element needed for the L-PNTD interaction or directly interacts with L itself. It is important that minigenome reporter activity is a function of gene expression, which itself is a function of multiple activities. These include transcription, transcript maturation, N-RNA complex formation, and replication of the minigenome. A minigenome reporter does not identify the step of gene expression being suppressed, but because our NMR experiments indicated that our region of interest bound LCTD, we hypothesize that our mutants impaired either the formation or the conformational regulation of the L-P complex. On the latter note, previous work (16, 18) has suggested that the unphosphorylated L-PNTD conformation is associated with initiation and has presumed that movement of the MTase domain would be required for transcript maturation.

Although residues in and around the phosphorylation site had been suggested to form a metal-binding pocket, since EDTA was necessary to visualize this signal using HSQC (24), this was not a result that our studies recapitulated. Amide peaks in both phosphorylated and unphosphorylated samples remained clustered along the 1H axis, indicating that both were in a disordered state, meaning that other structural rearrangements were also unlikely upon phosphorylation.

Using class averages generated from negative-stain EM, we found that the conformation of the L-PNTD complex in solution appears to change upon phosphorylation of PNTD. Specifically, a loss of definition for the accessory domains or the separation of the accessory domains from the core in the phosphorylated sample indicated that additional heterogeneity was present relative to that in the sample prepared with unphosphorylated PNTD. This resulted in conformations more similar to the noncompact forms predominant in the apo L sample. Given that our NMR observations were consistent with a loss of interaction strength upon phosphorylation, and given that conformational compaction is a well-characterized effect of the unphosphorylated and more strongly binding PNTD, it seems intuitive to suggest that the phosphorylated cofactor dissociates from the LCTD binding site more frequently. A visual model for this change to L-PNTD interactions is presented in Fig. 7. It should be noted that a full dissociation of PNTD could also explain the emergence of the noncompact apo-like states observed in our EM studies. Regardless, interactions between the L and P components can still occur in the phosphorylated state.

FIG 7.

FIG 7

Model for L-PNTD conformation and phosphorylation. In the apo state, the accessory domains of L are not coordinated with the core, resulting in high conformational heterogeneity. The PNTD binding events in the LCTD, RDRP domain, and connector domain restrain the movement of the accessories relative to the core. When phosphorylation interferes with the PNTD-LCTD interaction, part of the L-PNTD complex samples a state in which the movement of the accessory domains is not comparably restrained, resulting in greater conformational heterogeneity.

The results of this study are particularly interesting when contextualized with the emerging structural picture of polymerase initiation in the Mononegavirales. In VSV and RABV, a conserved priming-capping loop is thought to be required in a forward conformation for the initiation of RNA synthesis, but this conformation is presumptively prohibitive of RNA product ejection (18, 21, 32). In RSV and HMPV, however, this loop can be observed in a retracted state, while the accessory domains remain highly flexible (19, 20). Furthermore, studies in PIV5 (22) show a compacted state similar to that of VSV or RABV, but one in which the position of the methyltransferase and C-terminal domains has changed. In this structure the priming-capping loop is retracted, but a different “intrusion” loop is forward. While the existence of comparable states in the VSV L-P system has not yet been demonstrated, it is tempting to speculate that the accessory domains of VSV L sample multiple functionally relevant conformations. The increased conformational heterogeneity observed with cofactor phosphorylation may play a role in regulating the switch to these conformations. In the future, additional structures of the polymerase, polymerase-template, and polymerase-product complexes will shed light on this matter.

MATERIALS AND METHODS

Molecular cloning.

The sequences of VSV L1596–2109 and VSV P35–106 were amplified from whole-gene plasmids using primers with the sequences 5′-ACGGTCTCAAGGTATGAGCTATCCCCCTTGGG and 5′-CCGCTCGAGTTAATCTCTCCAAGAGTTTTCCTCATGTAG (VSV L) and 5′-ACGGTCTCAAGGTTCCAATTATGAGTTGTTCCAAGAG and 5′-CACCGCTCGAGTTACGAAGTGAATACAACATCCACGTC (VSV P). Amplification products were cloned into a SUMOpro Gene Fusion Technology Kanamycin (SpGFTk) vector (LifeSensors, Malvern, PA) using the BsaI and XhoI restriction enzymes and T4 DNA ligase. These plasmids were labeled Sp-L1596-2109 and Sp-P35-106, respectively.

Protein expression and purification.

Plasmids Sp-L1596-2109 and Sp-P35-106 were transformed into Escherichia coli SoluBL21 cells (Genlantis, San Diego, CA) using heat shock. Cells were grown under kanamycin selection. Overnight starter cultures were prepared using a single transformant colony in either LB broth for conventional expression (Fisher, Fair Lawn, NJ) or M9 minimal medium for isotopic labeling using [15N]ammonium chloride and [13C]glucose (Cambridge Isotope Laboratories, Andover, MA). Starter cultures were grown overnight at 37°C, pelleted, resuspended in fresh medium with antibiotic, and diluted 1:100 into expression cultures. LB and M9 cultures were grown to optical density at 600 nm (OD600) values of 0.4 to 0.6 and 0.7, respectively. Cultures were then cooled to 18°C, and protein expression was induced by adding isopropyl-β-d-1-thiogalactopyranoside (IPTG) to a final concentration of 0.5 mM. Induced cultures were incubated overnight at 18°C.

Induced cultures were pelleted at 6,000 × g for 15 min at room temperature. Pellets were resuspended in binding buffer (500 mM sodium chloride, 10% [vol/vol] glycerol, 5 mM imidazole, 20 mM Tris [pH 7.9]) at a ratio of 30 ml binding buffer for each 1 liter of culture pelleted. Initial purification was performed using nickel affinity chromatography. Cell pellets were sonicated and pelleted at 27,000 × g for 30 min at 4°C. Supernatants were passed over 5 ml Chelating Sepharose Fast Flow beads (GE Healthcare, Pittsburgh, PA) per 2 liters of expression culture. Beads were washed using 10 column volumes (CV) binding buffer and 5 CV wash buffer (binding buffer with 60 mM imidazole). P35–106 was eluted using eluting buffer (binding buffer with 1 M imidazole). L1596–2109 was eluted using stripping buffer (500 mM sodium chloride, 10% [vol/vol] glycerol, 20 mM Tris, 100 mM EDTA [pH 7.9]).

L1596–2109 was exchanged to HA buffer [500 mM sodium chloride, 10% (vol/vol) glycerol, 20 mM HEPES, 1 mM Tris(2-carboxyethyl)phosphine (TCEP), 0.02% (wt/vol) sodium azide (pH 7.0)] and loaded onto a 5-ml HiTrap heparin column (GE Healthcare, Pittsburgh, PA). The protein was eluted with a gradient of HA buffer and HB buffer (equivalent to HA but with 1 M sodium chloride). The heparin eluate was treated with 2 μg SUMO protease to 1 mg of the protein of interest and was incubated overnight at 4°C. Completion of digestion was validated by SDS-PAGE. The digested protein was purified on a HiLoad 16/600 Superdex 200 pg column (GE Healthcare, Pittsburgh, PA) using HB buffer.

P35–106 was treated with SUMO protease as described above. Following a second round of nickel affinity chromatography to remove the SUMO tag, P was exchanged to RQA buffer (150 mM sodium chloride, 20 mM Tris, 0.02% [wt/vol] sodium azide [pH 7.5]) using a HiPrep 26/10 desalting column (GE Healthcare, Pittsburgh, PA) and was purified using anion exchange on a 1-ml Resource Q column (GE Healthcare, Pittsburgh, PA) with a gradient of RQA buffer and RQB buffer (equivalent to RQA buffer but with 1 M sodium chloride). The ion-exchange eluate was purified on a HiLoad 16/600 Superdex 75 pg column (GE Healthcare, Pittsburgh, PA) using HB buffer.

Full-length L was expressed by infecting Sf21 cells with a baculovirus carrying a polyhistidine-tagged L construct (44) and was purified using nickel affinity chromatography as described previously (45).

In vitro phosphorylation of VSV P.

Purified P35-106 was exchanged to phosphorylation buffer (150 mM sodium chloride, 10 mM magnesium chloride, 1 mM β-mercaptoethanol, 25 mM Tris [pH 7.5]) using a HiPrep 26/10 desalting column. To the sample was added ATP to a final concentration of 1 mM and casein kinase subunit IIα to a final concentration of 5 ng/μl enzyme to 30 μM P35–106. Phosphorylation was validated using mass spectrometry (Fig. 3), and the phosphorylated protein was repurified using size exclusion chromatography as described above.

Nuclear magnetic resonance spectroscopy.

NMR experiments were carried out at the Central Alabama High-Field NMR facility on a Bruker Avance III spectrometer with a TCI CryoProbe. Experiments were carried out at 10°C on a 600-MHz instrument. Data were analyzed using NMRPipe (46) and NMR View (47). Before analysis, proteins were exchanged into NMR buffer (200 mM sodium chloride, 10% [vol/vol] glycerol, 20 mM HEPES, 1 mM TCEP [pH 6.8]) with a HiPrep 26/10 desalting column. Resonance assignments were carried out using standard experiments (48).

Amino acid sequence alignments.

Sequence alignments were performed using ClustalX2 (49), and phosphoprotein amino acid sequences of the following viruses were retrieved from the UniProt database: vesicular stomatitis Indiana virus (P04880), vesicular stomatitis New Jersey virus (I7CGJ1), vesicular stomatitis Alagoas virus (B3FRL2), Carajas virus (A0A0D3R1C6), Chandipura virus (E3T3B5), Cocal virus (B3FRK7), Isfahan virus (Q5K2K6), Maraba virus (F8SPF1), Piry virus (Q01769), Jurona virus (I1SV83), Perinet virus (I1SV88), Yug Bogdanovac virus (K4FFQ0), pike fry virus (C3VM12), and spring viremia of carp virus (A8VJA2).

Minigenome reporter system.

A minigenome assay was carried out as described previously (17). The reporter assay was performed using three technical replicates. The expression levels of mutagenized VSV P were examined by Western blotting as described previously (11). Mutagenesis on the VSV P plasmid was carried out using a Q5 site-directed mutagenesis kit (New England BioLabs, Ipswich, MA).

Electron microscopy.

VSV L was loaded onto 3-nm-thick continuous carbon grids over lacey carbon grids (Electron Microscopy Sciences, Hatfield, PA) at a concentration of 0.15 μM, with and without 1.5 μM phosphorylated or unphosphorylated VSV P35–106. Dilutions to final concentrations were carried out in phosphorylation buffer. Grids were washed with water prior to staining with 0.75% (wt/vol) uranyl formate. Grids were imaged on an FEI Tecnai F20 transmission electron microscope using a Gatan K3 direct electron detector and an operating voltage of 200 keV. The images were collected at a nominal magnification of ×40,200, corresponding to 1.24 Å/pixel. Images were prepared in EMAN, version 2.2 (50), using e2proc2d.py, and data processing was carried out using RELION, version 3.0.8 (51). Final 2D class averages were made using 3,708 particles and 13 classes for apo L, 7,392 particles and 21 class averages for the unphosphorylated sample, and 3,312 particles and 12 class averages for the phosphorylated sample.

ACKNOWLEDGMENTS

This work was supported by the National Institutes of Health (grants AI116738 to T.J.G., AI134693 to C.M.P., and AI093569 and AI146172 to T.O.). The Bruker 600-MHz instrument used in this study was funded by the National Cancer Institute (grant 1P30 CA-13148) and the National Center for Research Resources (grant 1s10 RR022994-01A1). Electron microscopy experiments were carried out at the UAB Cryo-EM Facility, which is supported by a grant from the UAB Health Sciences Foundation General Endowment Fund (HSF-GEF) to Terje Dokland. Antibodies were generously provided by Amiya Banerjee.

REFERENCES

  • 1.Emerson SU, Wagner RR. 1972. Dissociation and reconstitution of the transcriptase and template activities of vesicular stomatitis B and T virions. J Virol 10:297–309. doi: 10.1128/JVI.10.2.297-309.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Naito S, Ishihama A. 1976. Function and structure of RNA polymerase from vesicular stomatitis virus. J Biol Chem 251:4307–4314. doi: 10.1016/S0021-9258(17)33297-0. [DOI] [PubMed] [Google Scholar]
  • 3.Emerson SU, Wagner RR. 1973. L protein requirement for in vitro RNA synthesis by vesicular stomatitis virus. J Virol 12:1325–1335. doi: 10.1128/JVI.12.6.1325-1335.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Emerson SU, Yu Y. 1975. Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus. J Virol 15:1348–1356. doi: 10.1128/JVI.15.6.1348-1356.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Stojdl D, Lichty B, Knowles S, Marius R, Atkins H, Sonenberg N, Bell JC. 2000. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med 6:821–825. doi: 10.1038/77558. [DOI] [PubMed] [Google Scholar]
  • 6.Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell P-S, Hossmann S, Watle SV, Kondé MK, Kéïta S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Røttingen J-A, Kieny M-P. 2017. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 389:505–518. doi: 10.1016/S0140-6736(16)32621-6. [DOI] [PubMed] [Google Scholar]
  • 7.Nie J, Li Q, Wu J, Zhao C, Hao H, Liu H, Zhang L, Nie L, Qin H, Wang M, Lu Q, Li X, Sun Q, Liu J, Fan C, Huang W, Xu M, Wang Y. 2020. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg Microbes Infect 9:680–686. doi: 10.1080/22221751.2020.1743767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Case JB, Rothlauf PW, Chen RE, Liu Z, Zhao H, Kim AS, Bloyet L-M, Zeng Q, Tahan S, Droit L, Ilagan MXG, Tartell MA, Amarasinghe G, Henderson JP, Miersch S, Ustav M, Sidhu S, Virgin HW, Wang D, Ding S, Corti D, Theel ES, Fremont DH, Diamond MS, Whelan SPJ. 2020. Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2. Cell Host Microbe 28:475–485. doi: 10.1016/j.chom.2020.06.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Case JB, Rothlauf PW, Chen RE, Kafai NM, Fox JM, Smith BK, Shrihari S, McCune BT, Harvey IB, Keeler SP, Bloyet L-M, Zhao H, Ma M, Adams LJ, Winkler ES, Holtzman MJ, Fremont DH, Whelan SPJ, Diamond MS. 2020. Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis in mice. Cell Host Microbe 28:465–474. doi: 10.1016/j.chom.2020.07.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Poch O, Blumberg BM, Bougueleret L, Tordo N. 1990. Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains. J Gen Virol 71:1153–1162. doi: 10.1099/0022-1317-71-5-1153. [DOI] [PubMed] [Google Scholar]
  • 11.Ogino T, Banerjee AK. 2007. Unconventional mechanism of mRNA capping by the RNA-dependent RNA polymerase of vesicular stomatitis virus. Mol Cell 25:85–97. doi: 10.1016/j.molcel.2006.11.013. [DOI] [PubMed] [Google Scholar]
  • 12.Grdzelishvili VZ, Smallwood S, Tower D, Hall RL, Hunt DM, Moyer SA. 2005. A single amino acid change in the L-polymerase protein of vesicular stomatitis virus completely abolishes viral mRNA cap methylation. J Virol 79:7327–7337. doi: 10.1128/JVI.79.12.7327-7337.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Li J, Fontaine-Rodriguez EC, Sean PJ, Whelan SPJ. 2005. Amino acid residues within conserved domain VI of the vesicular stomatitis virus large polymerase protein essential for mRNA cap methyltransferase activity. J Virol 79:13373–13384. doi: 10.1128/JVI.79.21.13373-13384.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Li J, Wang JT, Whelan SPJ. 2006. A unique strategy for mRNA cap methylation used by vesicular stomatitis virus. Proc Natl Acad Sci U S A 103:8493–8498. doi: 10.1073/pnas.0509821103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Banerjee AK, Rhodes DP. 1973. In vitro synthesis of RNA that contains polyadenylate by virion-associated RNA polymerase of vesicular stomatitis virus. Proc Natl Acad Sci U S A 70:3566–3570. doi: 10.1073/pnas.70.12.3566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Liang B, Li Z, Jenni S, Rahmeh AA, Morin BM, Grant T, Grigorieff N, Harrison SC, Whelan SPJ. 2015. Structure of the L protein of vesicular stomatitis virus from electron cryomicroscopy. Cell 162:314–327. doi: 10.1016/j.cell.2015.06.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Gould JR, Qiu S, Shang Q, Ogino T, Prevelige PE, Petit CM, Green TJ. 2020. The connector domain of vesicular stomatitis virus large protein interacts with the viral phosphoprotein. J Virol 94:e01729-19. doi: 10.1128/JVI.01729-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Jenni S, Bloyet L-M, Diaz-Avalos R, Liang B, Whelan SPJ, Grigorieff N, Harrison SC. 2020. Structure of the vesicular stomatitis virus L protein in complex with its phosphoprotein cofactor. Cell Rep 30:53–60. doi: 10.1016/j.celrep.2019.12.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Pan J, Qian X, Lattmann S, El Sahili A, Yeo T, Jia H, Cressey T, Ludeke B, Noton S, Kalocsay M, Fearns R, Lescar J. 2020. Structure of the human metapneumovirus polymerase phosphoprotein complex. Nature 577:275–279. doi: 10.1038/s41586-019-1759-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Gilman MSA, Liu C, Fung A, Behera I, Jordan P, Rigaux P, Ysebaert N, Tcherniuk S, Sourimant J, Eléouët J-F, Sutto-Ortiz P, Decroly E, Roymans D, Jin Z, McLellan JS. 2019. Structure of the respiratory syncytial virus polymerase complex. Cell 179:193–204. doi: 10.1016/j.cell.2019.08.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Horwitz JA, Jenni S, Harrison SC, Whelan SPJ. 2020. Structure of a rabies virus polymerase complex from electron cryo-microscopy. Proc Natl Acad Sci U S A 117:2099–2107. doi: 10.1073/pnas.1918809117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Abdella R, Aggarwal M, Okura T, Lamb RA, He Y. 2020. Structure of a paramyxovirus polymerase complex reveals a unique methyltransferase-CTD conformation. Proc Natl Acad Sci U S A 117:4931–4941. doi: 10.1073/pnas.1919837117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Green TJ, Macpherson S, Qiu S, Lebowitz J, Wertz GW, Luo M. 2000. Study of the assembly of vesicular stomatitis virus N protein: role of the P protein. J Virol 74:9515–9524. doi: 10.1128/jvi.74.20.9515-9524.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Yabukarski F, Leyrat C, Martinez N, Communie G, Ivanov I, Ribeiro EA, Buisson M, Gerard FC, Bourhis J-M, Jensen MR, Bernadó P, Blackledge M, Jamin M. 2016. Ensemble structure of the highly flexible complex formed between vesicular stomatitis virus unassembled nucleoprotein and its phosphoprotein chaperone. J Mol Biol 428:2671–2694. doi: 10.1016/j.jmb.2016.04.010. [DOI] [PubMed] [Google Scholar]
  • 25.Rahmeh AA, Morin B, Schenk AD, Liang B, Heinrich BS, Brusic V, Walz T, Whelan SPJ. 2012. Critical phosphoprotein elements that regulate polymerase architecture and function in vesicular stomatitis virus. Proc Natl Acad Sci U S A 109:14628–14633. doi: 10.1073/pnas.1209147109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Leyrat C, Schneider R, Ribeiro EA, Jr, Yabukarski F, Yao M, Gérard FCA, Jensen MR, Ruigrok RWH, Blackledge M, Jamin M. 2012. Ensemble structure of the modular and flexible full-length vesicular stomatitis virus phosphoprotein. J Mol Biol 423:182–197. doi: 10.1016/j.jmb.2012.07.003. [DOI] [PubMed] [Google Scholar]
  • 27.Ding H, Green TJ, Luo M. 2004. Crystallization and preliminary X-ray analysis of a proteinase-K-resistant domain within the phosphoprotein of vesicular stomatitis virus (Indiana). Acta Crystallogr D Biol Crystallogr 60:2087–2091. doi: 10.1107/S0907444904024102. [DOI] [PubMed] [Google Scholar]
  • 28.Ding H, Green TJ, Lu S, Luo M. 2006. Crystal structure of the oligomerization domain of the phosphoprotein of vesicular stomatitis virus. J Virol 80:2808–2814. doi: 10.1128/JVI.80.6.2808-2814.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Gerard FCA, de Almeida Ribeiro E, Jr, Albertini AAV, Gutsche I, Zaccai G, Ruigrok RWH, Jamin M. 2007. Unphosphorylated Rhabdoviridae phosphoproteins form elongated dimers in solution. Biochemistry 46:10328–10338. doi: 10.1021/bi7007799. [DOI] [PubMed] [Google Scholar]
  • 30.Emerson SU, Schubert M. 1987. Location of the binding domains for the RNA polymerase L and the ribonucleocapsid template within different halves of the NS phosphoprotein of vesicular stomatitis virus. Proc Natl Acad Sci U S A 84:5655–5659. doi: 10.1073/pnas.84.16.5655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Green TJ, Luo M. 2009. Structure of the vesicular stomatitis virus nucleocapsid in complex with the nucleocapsid-binding domain of the small polymerase cofactor, P. Proc Natl Acad Sci U S A 106:11713–11718. doi: 10.1073/pnas.0903228106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ogino M, Gupta N, Green TJ, Ogino T. 2019. A dual-functional priming-capping loop of rhabdoviral RNA polymerases directs terminal de novo initiation and capping intermediate formation. Nucleic Acids Res 47:299–309. doi: 10.1093/nar/gky1058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Takacs AM, Barik S, Das T, Banerjee AK. 1992. Phosphorylation of specific serine residues within the acidic domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro. J Virol 66:5842–5848. doi: 10.1128/JVI.66.10.5842-5848.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Gao Y, Lenard J. 1995. Multimerization and transcriptional activation of the phosphoprotein (P) of vesicular stomatitis virus by casein kinase-II. EMBO J 14:1240–1247. doi: 10.1002/j.1460-2075.1995.tb07107.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Barik S, Banerjee AK. 1992. Phosphorylation by cellular casein kinase II is essential for transcriptional activity of vesicular stomatitis virus phosphoprotein P. Proc Natl Acad Sci U S A 89:6570–6574. doi: 10.1073/pnas.89.14.6570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Sokol F, Clark HF. 1973. Phosphoproteins, structural components of rhabdoviruses. Virology 52:246–263. doi: 10.1016/0042-6822(73)90413-3. [DOI] [PubMed] [Google Scholar]
  • 37.Mondal A, Victor KG, Pudupakam RS, Lyons CE, Wertz W. 2014. Newly identified phosphorylation site in the vesicular stomatitis virus P protein is required for viral RNA synthesis. J Virol 88:1461–1472. doi: 10.1128/JVI.02384-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Chattopadhyay D, Banerjee AK. 1987. Phosphorylation within a specific domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro. Cell 49:407–414. doi: 10.1016/0092-8674(87)90293-5. [DOI] [PubMed] [Google Scholar]
  • 39.Pattnaik AK, Hwang L, Li T, Englund N, Mathur M, Das T, Banerjee AK. 1997. Phosphorylation within the amino-terminal acidic domain I of the phosphoprotein of vesicular stomatitis virus is required for transcription but not for replication. J Virol 71:8167–8175. doi: 10.1128/JVI.71.11.8167-8175.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Chen L, Zhang S, Banerjee AK, Chen M. 2013. N-terminal phosphorylation of phosphoprotein of vesicular stomatitis virus is required for preventing nucleoprotein from binding to cellular RNAs and for functional template formation. J Virol 87:3177–3186. doi: 10.1128/JVI.02761-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Pfaller CK, Cattaneo R, Schnell MJ. 2015. Reverse genetics of Mononegavirales: how they work, new vaccines, and new cancer therapeutics. Virology 479–480:331–344. doi: 10.1016/j.virol.2015.01.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Fearns R, Plemper RK. 2017. Polymerases of paramyxoviruses and pneumoviruses. Virus Res 234:87–102. doi: 10.1016/j.virusres.2017.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Spadafora D, Canter DM, Jackson RL, Perrault J. 1996. Constitutive phosphorylation of the vesicular stomatitis virus P protein modulates polymerase complex formation but is not essential for transcription or replication. J Virol 70:4538–4548. doi: 10.1128/JVI.70.7.4538-4548.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ogino T, Yadav SP, Banerjee AK. 2010. Histidine-mediated RNA transfer to GDP for unique mRNA capping by vesicular stomatitis virus RNA polymerase. Proc Natl Acad Sci U S A 107:3463–3468. doi: 10.1073/pnas.0913083107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ogino T. 2013. In vitro capping and transcription of rhabdoviruses. Methods 59:188–198. doi: 10.1016/j.ymeth.2012.05.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. 1995. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6:277–293. doi: 10.1007/BF00197809. [DOI] [PubMed] [Google Scholar]
  • 47.Johnson BA, Blevins RA. 1994. NMR View: a computer program for the visualization and analysis of NMR data. J Biomol NMR 4:603–614. doi: 10.1007/BF00404272. [DOI] [PubMed] [Google Scholar]
  • 48.Muhandiram DR, Kay LE. 1994. Gradient-enhanced triple-resonance three-dimensional NMR experiments with improved sensitivity. J Magn Reson Ser B 103:203–216. doi: 10.1006/jmrb.1994.1032. [DOI] [Google Scholar]
  • 49.Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. 2007. Clustal W and Clustal X version 2.0. Bioinformatics 23:2947–2948. doi: 10.1093/bioinformatics/btm404. [DOI] [PubMed] [Google Scholar]
  • 50.Tang G, Peng L, Baldwin PR, Mann DS, Jiang W, Rees I, Ludtke SJ. 2007. EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol 157:38–46. doi: 10.1016/j.jsb.2006.05.009. [DOI] [PubMed] [Google Scholar]
  • 51.Zivanov J, Nakane T, Forsberg BO, Kimanius D, Hagen WJH, Lindahl E, Scheres SHW. 2018. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 7:e42166. doi: 10.7554/eLife.42166. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES